These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20656084)

  • 1. Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study.
    Juillard A; Falgayrac G; Cortet B; Vieillard MH; Azaroual N; Hornez JC; Penel G
    Bone; 2010 Nov; 47(5):895-904. PubMed ID: 20656084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid.
    Gamsjaeger S; Buchinger B; Zwettler E; Recker R; Black D; Gasser JA; Eriksen EF; Klaushofer K; Paschalis EP
    J Bone Miner Res; 2011 Jan; 26(1):12-8. PubMed ID: 20645415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Gasser JA; Green JR; Shen V; Ingold P; Rebmann A; Bhatnagar AS; Evans DB
    Bone; 2006 Oct; 39(4):787-95. PubMed ID: 16844441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
    Amanat N; McDonald M; Godfrey C; Bilston L; Little D
    J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
    Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.
    Little DG; Smith NC; Williams PR; Briody JN; Bilston LE; Smith EJ; Gardiner EM; Cowell CT
    J Bone Miner Res; 2003 Jul; 18(7):1300-7. PubMed ID: 12854841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer.
    Ryan CW; Huo D; Demers LM; Beer TM; Lacerna LV
    J Urol; 2006 Sep; 176(3):972-8; discussion 978. PubMed ID: 16890673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between infrared and Raman spectroscopic analysis of maturing rabbit cortical bone.
    Turunen MJ; Saarakkala S; Rieppo L; Helminen HJ; Jurvelin JS; Isaksson H
    Appl Spectrosc; 2011 Jun; 65(6):595-603. PubMed ID: 21639980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
    Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
    J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site.
    Biver E; Vieillard MH; Cortet B; Salleron J; Falgayrac G; Penel G
    Bone; 2010 Mar; 46(3):643-8. PubMed ID: 19895916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.
    Mukherjee S; Song Y; Oldfield E
    J Am Chem Soc; 2008 Jan; 130(4):1264-73. PubMed ID: 18173269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and spectroscopic studies of bisphosphonate-bone interactions. The Raman, NMR and crystallographic investigations of Ca-HEDP complexes.
    Cukrowski I; Popović L; Barnard W; Paul SO; van Rooyen PH; Liles DC
    Bone; 2007 Oct; 41(4):668-78. PubMed ID: 17644459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
    Recker RR; Delmas PD; Halse J; Reid IR; Boonen S; García-Hernandez PA; Supronik J; Lewiecki EM; Ochoa L; Miller P; Hu H; Mesenbrink P; Hartl F; Gasser J; Eriksen EF
    J Bone Miner Res; 2008 Jan; 23(1):6-16. PubMed ID: 17892374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and plasma protein binding of zoledronic acid.
    Weiss HM; Pfaar U; Schweitzer A; Wiegand H; Skerjanec A; Schran H
    Drug Metab Dispos; 2008 Oct; 36(10):2043-9. PubMed ID: 18625688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
    Shapiro J; Smith B; Beck T; Ballard P; Dapthary M; BrintzenhofeSzoc K; Caminis J
    Calcif Tissue Int; 2007 May; 80(5):316-22. PubMed ID: 17417700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment.
    Bohic S; Rey C; Legrand A; Sfihi H; Rohanizadeh R; Martel C; Barbier A; Daculsi G
    Bone; 2000 Apr; 26(4):341-8. PubMed ID: 10719276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid-induced IPP/ApppI production in vivo.
    Mönkkönen H; Ottewell PD; Kuokkanen J; Mönkkönen J; Auriola S; Holen I
    Life Sci; 2007 Sep; 81(13):1066-70. PubMed ID: 17850825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.